Funded Projects

Cognitive neuroscience has traditionally focused on identifying the neural basis of psychological traits or state effects across large samples of participants. Recently, researchers have pushed towards providing more precise estimates of individual functional organization to better understand both psychological constructs as well as their supporting neural mechanisms.

Calcium imaging in freely behaving animals allows for the tracking of neuronal activity under approximately normal behavioral conditions. However, the slow response time of calcium imaging inhibits high resolution voltage and temporal measurements. To address this issue, modern molecular tools have been developed to optically report the high-speed dynamics of neurons more accurately.

The gut-brain axis is implicated in many essential physiological and psychological functions, ranging from feeding, emotion, motivation, to memory. As a critical component of the gut-brain axis, vagal sensory neurons exhibit distinct projection patterns to target specific visceral organs.

Membrane transport proteins are essential for life. They transport essential nutrients and minerals across the membrane barrier that surrounds each cell in the human body. This transport is necessary for every living process – from eating and breathing to learning and doing daily work.

StrokeCog is focused on cognitive problems after stroke. The team leads a study aimed at identifying if neuroinflammation plays an important role in the development of post-stroke cognitive decline.

The goal of the project is to create a transformative sensor technology to measure complex forms of chemical communication in the living brain, in real time.

Elucidating the development of the infant’s brain structure & function.

The NeuroPlant Initiative aims to leverage a botanical armamentarium to manipulate the brain — by building a pipeline to explore chemicals synthesized in plants as potential new treatments for neurological disease and as a window into the chemistry of the brain.

This team will use their Neuroscience:Translate award to develop a large-scale bi-directional neural interface that will restore high-fidelity vision to people blinded by retinal degeneration.

This team will use their Neuroscience:Translate award to employ a novel therapeutic technique to correct pathogenic mutations causing Parkinson’s disease.

This team will use their Neuroscience:Translate award to develop an entirely new class of ischemic stroke treatment device that will lead to improved clot extraction to improve the success of endovascular thrombectomy.

This team will use their Neuroscience:Translate award to develop the first wearable ultrasound (US) device for the treatment of inflammatory diseases, such as Rheumatoid Arthritis (RA) and Inflammatory Bowel Disease.

This team is developing a small molecule that targets a voltage-gated ion channel within the inner ear for the symptomatic relief of peripheral vertigo attacks. They will use their Neuroscience:Translate award to further develop this molecule to restore normal function and improve activities of daily living for patients experiencing peripheral vertigo.

This team has identified a promising protein-based therapeutic to improve stroke recovery.  The team will use the Neuroscience:Translate award to identify key components of this protein to maximize its therapeutic potential for stroke treatments.

This team recently identified a selective biomarker of inflammation-promoting immune cells in the central nervous system. They will use their Neuroscience:Translate award to develop non-invasive molecular imaging strategies to distinguish between harmful (pro-inflammatory) and helpful (anti-inflammatory) immune cells in patients with Multiple sclerosis (MS).

This team has developed a new therapy for patients with spinal cord injury, involving injection into the spinal cord of patient-derived stem cells within an engineered protective gel. They will use their Neuroscience:Translate award to further test and develop this novel therapy in preparation for first-in-human clinical trials. 

This team recently discovered that a small molecule they had originally developed to treat Parkinson’s disease can also reduce the volume of glioblastoma tumors – the most common form of aggressive brain tumor — by targeting the mitochondrial protein Miro1. They will use their Neuroscience:Translate award to study the mechanisms of the compound’s anti-tumor action and prepare to apply for investigational-new-drug status to move this discovery toward the clinic.

Project's stimulation method may provide a powerful tool to reduce disability after a stroke, and the wearable form factor allows users to receive intensive therapy during their normal daily routine

Developing an automated seizure detection and localization system based on deep neural networks, EEG data, and real-time video with the goal to dramatically increase neurologist diagnostic capabilities while improving quality of care.

Developing a protein-engineered nerve implant that mimics the biochemical and mechanical cues of native tissue in order to enhance the potential for neural regeneration following injury.